Phase 2 Study of the Combination of Ibrutinib Plus Venetoclax in Subjects With Treatment-Naïve Chronic Lymphocytic Leukaemia / Small Lymphocytic Lymphoma

Project: Research

Project Description


StatusActive
Effective start/end date8/10/197/10/24

Keywords

  • clinical trial
  • treatment efficacy
  • lymphoma
  • leukemia